Sanofi (0O59) Share Forecast & Price Target

11 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

0O59 Analyst Ratings

Moderate Buy

5 Buy

5 Hold

0 Sell

Based on 10 analysts giving stock ratings to

Sanofi

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

0O59 Stock 12 Month Forecast

Average Price Target

€93.02

▲(19.72% Upside)

Based on 10 Wall Street analysts offering 12 month price targets for Sanofi in the last 3 months. The average price target is €93.02 with a high forecast of €106.21 and a low forecast of €78.00. The average price target represents a 19.72% change from the last price of €77.70.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"73":"€73","90":"€90","107":"€107","81.5":"€81.5","98.5":"€98.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":106.21,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€106.21</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":93.02333333333334,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€93.02</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":78,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€78.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[73,81.5,90,98.5,107],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Dec<br/>2025","6":"Mar<br/>2026","9":"Jun<br/>2026","12":"Sep<br/>2026","25":"Sep<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,77.355,79.57461538461538,81.79423076923077,84.01384615384616,86.23346153846154,88.45307692307692,90.6726923076923,92.8923076923077,95.11192307692308,97.33153846153846,99.55115384615384,101.77076923076922,103.99038461538461,{"y":106.21,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,77.355,78.56025641025641,79.76551282051282,80.97076923076924,82.17602564102565,83.38128205128206,84.58653846153847,85.79179487179488,86.99705128205129,88.2023076923077,89.40756410256411,90.61282051282052,91.81807692307693,{"y":93.02333333333334,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,77.355,77.40461538461538,77.45423076923078,77.50384615384615,77.55346153846155,77.60307692307693,77.6526923076923,77.7023076923077,77.75192307692308,77.80153846153846,77.85115384615385,77.90076923076923,77.95038461538462,{"y":78,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":80.202,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 43,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":80.212,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 50,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":82.958,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 46,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":81.94,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 35,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 7, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.526,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 25,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":76.348,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 25, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.155,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":78.536,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":75.59,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 11,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.6,"date":1780272000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 9, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.029,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":74.25,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":77.355,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 12,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 12, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€106.21

Average Price Target€93.02

Lowest Price Target€78.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Emmanuel Papadakis

Deutsche Bank

€95

Buy

22.27%

Upside

Reiterated

09/02/26

Deutsche Bank Reaffirms Their Buy Rating on Sanofi (SNYNF)

Luisa Hector

Berenberg Bank

€105

Buy

35.14%

Upside

Reiterated

08/24/26

Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (NASDAQ: RANI) and Sanofi (Other OTC: SNYNF)

Colin White

UBS

€78

Hold

0.39%

Upside

Reiterated

08/19/26

Sanofi (SNYNF) Gets a Hold from UBS

Sarita Kapila

Morgan Stanley

€86→€82

Hold

5.53%

Upside

Reiterated

08/11/26

Sanofi price target lowered to EUR 82 from EUR 86 at Morgan StanleySanofi price target lowered to EUR 82 from EUR 86 at Morgan Stanley

Michael Leuchten

Jefferies

€100

Buy

28.70%

Upside

Reiterated

08/07/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Qiagen (NYSE: QGEN) and Sanofi (Other OTC: SNYNF)

Justin Smith

Bernstein

€107→€106.21

Buy

36.69%

Upside

Reiterated

08/04/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Elmar Kraus

DZ BANK AG

―

Buy

―

Reiterated

07/31/26

Analysts Are Bullish on Top Healthcare Stocks: Neurocrine (NBIX), Sanofi (SNYNF)

Richard Vosser

J.P. Morgan

€95

Hold

22.27%

Upside

Reiterated

07/31/26

Sanofi (SNYNF) Gets a Hold from J.P. Morgan

Sachin Jain

Bank of America Securities

€92

Hold

18.40%

Upside

Reiterated

07/30/26

Analysts' Top Healthcare Picks: Tilray (TLRY), Humana (HUM)

James Quigley

Goldman Sachs

€89→€84

Hold

8.11%

Upside

Reiterated

07/06/26

Analysts Offer Insights on Healthcare Companies: Celcuity (NASDAQ: CELC), Dogwood Therapeutics (NASDAQ: DWTX) and Sanofi (Other OTC: SNYNF)

Nicolas Pauillac

Kepler Capital

€85

Hold

9.40%

Upside

Reiterated

04/23/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Sanofi (Other OTC: SNYNF)

James Gordon CFA

Barclays

€85

Hold

9.40%

Upside

Reiterated

04/23/26

Analysts Conflicted on These Healthcare Names: BridgeBio Oncology Therapeutics (NASDAQ: BBOT), Sanofi (Other OTC: SNYNF) and Molina Healthcare (NYSE: MOH)

Graham Parry

Citi

€85→€80

Hold

2.96%

Upside

Reiterated

02/20/26

Sanofi price target lowered to EUR 80 from EUR 85 at CitiSanofi price target lowered to EUR 80 from EUR 85 at Citi

David Risinger

Leerink Partners

―

Buy

―

Reiterated

12/24/25

Analysts' Top Healthcare Picks: Sanofi (SNYNF), Genmab (GMAB)

Rajesh Kumar

HSBC

€102→€100

Buy

28.70%

Upside

Reiterated

12/10/25

Sanofi price target lowered to EUR 100 from EUR 102 at HSBCSanofi price target lowered to EUR 100 from EUR 102 at HSBC

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Emmanuel Papadakis

Deutsche Bank

€95

Buy

22.27%

Upside

Reiterated

09/02/26

Deutsche Bank Reaffirms Their Buy Rating on Sanofi (SNYNF)

Luisa Hector

Berenberg Bank

€105

Buy

35.14%

Upside

Reiterated

08/24/26

Analysts Offer Insights on Healthcare Companies: Rani Therapeutics Holdings (NASDAQ: RANI) and Sanofi (Other OTC: SNYNF)

Colin White

UBS

€78

Hold

0.39%

Upside

Reiterated

08/19/26

Sanofi (SNYNF) Gets a Hold from UBS

Sarita Kapila

Morgan Stanley

€86→€82

Hold

5.53%

Upside

Reiterated

08/11/26

Sanofi price target lowered to EUR 82 from EUR 86 at Morgan StanleySanofi price target lowered to EUR 82 from EUR 86 at Morgan Stanley

Michael Leuchten

Jefferies

€100

Buy

28.70%

Upside

Reiterated

08/07/26

Analysts Have Conflicting Sentiments on These Healthcare Companies: Qiagen (NYSE: QGEN) and Sanofi (Other OTC: SNYNF)

Justin Smith

Bernstein

€107→€106.21

Buy

36.69%

Upside

Reiterated

08/04/26

Wall Street Analysts Are Bullish on Top Healthcare Picks

Elmar Kraus

DZ BANK AG

―

Buy

―

Reiterated

07/31/26

Analysts Are Bullish on Top Healthcare Stocks: Neurocrine (NBIX), Sanofi (SNYNF)

Richard Vosser

J.P. Morgan

€95

Hold

22.27%

Upside

Reiterated

07/31/26

Sanofi (SNYNF) Gets a Hold from J.P. Morgan

Sachin Jain

Bank of America Securities

€92

Hold

18.40%

Upside

Reiterated

07/30/26

Analysts' Top Healthcare Picks: Tilray (TLRY), Humana (HUM)

James Quigley

Goldman Sachs

€89→€84

Hold

8.11%

Upside

Reiterated

07/06/26

Analysts Offer Insights on Healthcare Companies: Celcuity (NASDAQ: CELC), Dogwood Therapeutics (NASDAQ: DWTX) and Sanofi (Other OTC: SNYNF)

Nicolas Pauillac

Kepler Capital

€85

Hold

9.40%

Upside

Reiterated

04/23/26

Analysts Offer Insights on Healthcare Companies: Roche Holding AG (Other OTC: RHHVF) and Sanofi (Other OTC: SNYNF)

James Gordon CFA

Barclays

€85

Hold

9.40%

Upside

Reiterated

04/23/26

Analysts Conflicted on These Healthcare Names: BridgeBio Oncology Therapeutics (NASDAQ: BBOT), Sanofi (Other OTC: SNYNF) and Molina Healthcare (NYSE: MOH)

Graham Parry

Citi

€85→€80

Hold

2.96%

Upside

Reiterated

02/20/26

Sanofi price target lowered to EUR 80 from EUR 85 at CitiSanofi price target lowered to EUR 80 from EUR 85 at Citi

David Risinger

Leerink Partners

―

Buy

―

Reiterated

12/24/25

Analysts' Top Healthcare Picks: Sanofi (SNYNF), Genmab (GMAB)

Rajesh Kumar

HSBC

€102→€100

Buy

28.70%

Upside

Reiterated

12/10/25

Sanofi price target lowered to EUR 100 from EUR 102 at HSBCSanofi price target lowered to EUR 100 from EUR 102 at HSBC

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

BTSGBrightSpring Health Services, Inc.

GPCRStructure Therapeutics, Inc. Sponsored ADR

BLTEBelite Bio, Inc. ADR

AMLXAmylyx Pharmaceuticals Inc

IMMXImmix Biopharma

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Sanofi

3 Months

Luisa HectorBerenberg Bank

Success Rate

15/25 ratings generated profit

Average Return

+1.37%

Copying Luisa Hector's trades and holding each position for 3 Months would result in 60.00% of your transactions generating a profit, with an average return of +1.37% per trade.

1 Year

David RisingerLeerink Partners

Success Rate

20/35 ratings generated profit

Average Return

+2.87%

Copying David Risinger's trades and holding each position for 1 Year would result in 57.14% of your transactions generating a profit, with an average return of +2.87% per trade.

2 Years

Emmanuel PapadakisDeutsche Bank

Success Rate

27/54 ratings generated profit

Average Return

-0.54%

Copying Emmanuel Papadakis's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of -0.54% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0O59 Analyst Recommendation Trends

Rating

May 26

Jun 26

Jul 26

Aug 26

Sep 26

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, 0O59 has received 12 Buy Ratings, 12 Hold Ratings, and 0 Sell Ratings. 0O59 average Analyst price target in the past 3 months is 93.02.

Each month's total comprises the sum of three months' worth of ratings.

0O59 Financial Forecast

0O59 Earnings Forecast

Next quarter’s earnings estimate for 0O59 is €2.83 with a range of €2.65 to €3.15. The previous quarter’s EPS was €2.09. 0O59 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.80% of the time in the same period. In the last calendar year 0O59 has Performed in-line its overall industry.

0O59 Sales Forecast

Next quarter’s sales forecast for 0O59 is €13.72B with a range of €12.99B to €14.08B. The previous quarter’s sales results were €22.11B. 0O59 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 50.04% of the time in the same period. In the last calendar year 0O59 has Performed in-line its overall industry.

0O59 Stock Forecast FAQ

What is GB:0O59’s average 12-month price target, according to analysts?

Based on analyst ratings, Sanofi’s 12-month average price target is 93.02.

What is GB:0O59’s upside potential, based on the analysts’ average price target?

Sanofi has 19.72% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Sanofi a Buy, Sell or Hold?

Sanofi has a consensus rating of Moderate Buy, which is based on 5 buy ratings, 5 hold ratings and 0 sell ratings.

What is Sanofi’s share price target?

The average share price target for Sanofi is 93.02. This is based on 10 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €106.21 ,and the lowest forecast is €78.00. The average share price target represents 19.72% Increase from the current price of €77.7.

What do analysts say about Sanofi?

Sanofi’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 10 Wall Streets Analysts.

How can I buy shares of Sanofi?

To buy shares of GB:0O59, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Sanofi (0O59) Share Forecast & Price Target

0O59 Analyst Ratings

0O59 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Sanofi

0O59 Analyst Recommendation Trends

0O59 Financial Forecast

0O59 Earnings Forecast

0O59 Sales Forecast

0O59 Stock Forecast FAQ

Detailed List of Analyst Forecasts